bf/NASDAQ:TNXP_icon.jpeg

COM:TONIXPHARMA

Tonix Pharmaceuticals

  • Stock

USD

Last Close

0.20

22/11 21:00

Market Cap

6.10M

Beta: -

Volume Today

1.92M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
asset turnover
15.29
-
cash conversion cycle
39.11
-
cash per share
707.11K
-
457.62K
35.28%
133.95K
70.73%
65.21K
51.32%
15.41K
76.37%
1.40K
90.92%
162.95
88.35%
98.06
39.82%
3.36
96.57%
company equity multiplier
1.10
-
1.17
6.59%
1.08
7.11%
1.09
0.20%
1.11
2.33%
1.55
39.00%
1.12
27.54%
1.10
1.68%
1.09
1.10%
days of inventory outstanding
-12.80
-
-55.11
330.56%
-30.55
44.57%
-26.19
14.27%
39.11
249.33%
days of payables outstanding
19.63
-
23.11
17.74%
8.17
64.65%
22.22
172.03%
19.47
12.37%
38.87
99.65%
33.23
14.52%
52.52
58.06%
26.27
49.97%
days of sales outstanding
dividend yield
0.46
-
1.31
187.81%
0.01
99.47%
0.08
-
ebit per revenue
-15.24
-
ebt per ebit
1.00
-
1.00
0.08%
1.00
0.10%
0.99
0.46%
0.99
0.10%
0.99
0.16%
1.00
0.64%
1.00
0.07%
0.98
1.64%
0.99
0.22%
effective tax rate
0.00
-
0.00
157.01%
0.01
58.30%
0.00
37.51%
-0.01
369.50%
0.01
192.34%
0.00
81.98%
0.00
45.32%
-0.04
5,443.18%
enterprise value multiple
-0.90
-
-2.60
188.45%
0.02
100.60%
-0.07
544.25%
0.68
1,075.44%
0.31
54.00%
0.23
27.56%
0.50
122.62%
0.29
42.88%
-58.01
20,251.54%
fixed asset turnover
free cash flow per share
-428.87K
-
-454.96K
6.08%
-191.70K
57.86%
-48.93K
74.47%
-14.76K
69.85%
-3.32K
77.50%
-120.79
96.36%
-60.85
49.63%
-4.09
93.28%
-0.01
99.84%
gross profit margin
0.39
-
interest coverage
14.17
-
inventory turnover
-28.51
-
-6.62
76.77%
-11.95
80.41%
-13.94
16.64%
9.33
166.97%
long term debt to capitalization
0.00
-
0.01
1,172.55%
0.00
73.71%
0.00
25.81%
net income per ebt
1
-
1
0%
1
0%
1
0%
1
0%
0.99
0.82%
1.00
0.68%
1.00
0.07%
1.04
4.43%
1
4.16%
net profit margin
-15.02
-
operating cash flow per share
-422.96K
-
-452.43K
6.97%
-191.36K
57.70%
-48.92K
74.44%
-14.75K
69.85%
-3.32K
77.51%
-102.69
96.91%
-41.47
59.61%
-2.74
93.38%
-0.01
99.78%
operating cycle
39.11
-
operating profit margin
-15.24
-
payables turnover
18.60
-
15.80
15.07%
44.69
182.91%
16.43
63.24%
18.75
14.12%
9.39
49.91%
10.99
16.99%
6.95
36.73%
13.89
99.90%
pretax profit margin
-15.02
-
price fair value
1.75
-
3.58
104.94%
0.72
79.82%
1.10
51.64%
0.30
72.43%
0.20
33.86%
0.73
267.24%
0.60
18.27%
0.42
29.82%
receivables turnover
return on assets
-0.70
-
-1.02
46.34%
-1.41
38.15%
-0.79
44.08%
-0.99
25.55%
-1.95
96.68%
-0.51
73.68%
-0.38
25.41%
-0.51
33.12%
-229.64
44,966.12%
return on capital employed
-0.76
-
-1.19
55.99%
-1.53
28.62%
-0.86
43.66%
-1.11
28.67%
-3.06
175.04%
-0.57
81.32%
-0.42
26.32%
-0.54
28.26%
-233.03
43,040.28%
return on equity
-0.77
-
-1.19
55.99%
-1.53
28.32%
-0.86
43.97%
-1.10
28.48%
-3.01
173.38%
-0.57
80.93%
-0.42
26.66%
-0.56
31.66%
total debt to capitalization
0.04
-
0.01
59.76%
0.00
70.47%
0.00
16.02%

All numbers in USD (except ratios and percentages)